Comment on Better Buy: Amgen Inc. vs. Biogen

Better Buy: Amgen Inc. vs. Biogen

If you're looking for unusually high returns on your capital, biotechnology remains a fairly safe bet, even despite its monstrous run-up over the past five years. The growing and aging global population, after all, is expected to drive an ever-increasing demand for the biologically based medicines that are at the very heart of the industry. With this in mind, Amgen (NASDAQ: AMGN) and Biogen (NASDAQ: BIIB) have both proven to be particularly outstanding vehicles to gain exposure to this high-flying industry.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News